PTH level might be associated with impaired quality of life in patients with nonsurgical hypoparathyroidism.
J Endocrinol Invest
; 46(12): 2471-2479, 2023 Dec.
Article
in En
| MEDLINE
| ID: mdl-37266827
ABSTRACT
OBJECTIVE:
Nonsurgical hypoparathyroidism (ns-HP) is a rare disease. There are few studies on Quality of Life (QoL) among patients with ns-HP. This study aimed to investigate the QoL among ns-HP patients with regular conventional treatment, and explore the influence factors affecting QoL among these Chinese ns-HP patients.METHODS:
This is a cross-sectional study comparing 101 patients identified as ns-HP and 101 healthy controls. The questionnaires of Short Form 36 Health Survey questionnaire version 2(SF-36v2) were used to evaluate QoL.RESULTS:
Scores of all eight subdomains of SF-36v2 and physical component scores (PCS), mental component scores (MCS) were significantly lower in the ns-HP group compared with the healthy controls. The indices of all subdomains of SF-36v2 between Q1 (the lowest quartile) and Q4 (the highest quartile) groups were compared, suggesting higher percentages of detectable parathyroid hormone (PTH) before treatment in Q4 group among all QoL indices except two subdomains (physical function and body pain).CONCLUSION:
Both mental and physical QoL were impaired in the ns-HP patients even with regular conventional treatment for hypocalcemia, which were more severe in cases with lower baseline PTH levels.Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Hypocalcemia
/
Hypoparathyroidism
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Aspects:
Patient_preference
Limits:
Humans
Language:
En
Journal:
J Endocrinol Invest
Year:
2023
Document type:
Article
Affiliation country:
China